Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes pharmacokinetics, safety, and preliminary efficacy of the ASTX727 and venetoclax combination in patients with acute myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ASTX727 (cedazuridine/decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING